Striatal binding of the PET ligand11C-raclopride is altered by drugs that modify synaptic dopamine levels-Reference-Cited by-同舟云学术

Striatal binding of the PET ligand11C-raclopride is altered by drugs that modify synaptic dopamine levels

Published:1993-04 Issue:4 Volume:13 Page:350-356
ISSN:0887-4476
Container-title:Synapse
language:en
Short-container-title:Synapse

Author:

Dewey Stephen L.,Smith Gwenn S.,Logan Jean,Brodie Jonathan D.,Fowler Joanna S.,Wolf Alfred P.

Publisher

Wiley

Subject

Cellular and Molecular Neuroscience

Reference48 articles.

1. The dopamine uptake inhibitor GBR 12909: selectivity and molecular mechanism of action

2. (1987) Clinical effects of central nervous system stimulants: A selective update. In: Brain Reward Systems and Abuse. and eds. Raven Press, New York, pp. 109-127.

3. Quantitation of the human basal ganglia with positron emission tomography: a phantom study of the effect of contrast and axial positioning

4. Brain dopamine and the syndromes of Parkinson and Huntington Clinical, morphological and neurochemical correlations

Cited by 264 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative pharmacology and abuse potential of oral dexamphetamine and lisdexamfetamine—A literature review;Human Psychopharmacology: Clinical and Experimental;2024-07-18

2. Dopamine release in human associative striatum during reversal learning;Nature Communications;2024-01-02

3. PET/SPECT: quantitative imaging and data analysis;Transpathology;2024

4. Beyond monoamines: II. Novel applications for PET imaging in psychiatric disorders;Journal of Neurochemistry;2022-07-29

5. Impact of an Adenosine A_2A Receptor Agonist and Antagonist on Binding of the Dopamine D₂ Receptor Ligand [¹¹C]raclopride in the Rodent Striatum;Molecular Pharmaceutics;2022-07-18